Open AccessA Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials
Author(s) -
Susan E. Shoaf,
John Ouyang,
Olga Sergeyeva,
Alvin Estilo,
Hui Li,
Deborah Leung
Publication year - 2020
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.08170719
Subject(s) - tolvaptan , medicine , autosomal dominant polycystic kidney disease , statin , placebo , rosuvastatin , adverse effect , kidney disease , renal function , urology , pharmacology , kidney , hyponatremia , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom